Contact number
202 662 6000Provided by Chambers
Covington & Burling LLP is sought after for the quality of its regulatory advice on a range of issues including pharmacovigilance, good manufacturing practices and post-approval compliance. It has a wealth of experience assisting with strategic partnership formations and M&A, as well as venture fund investments and spinoff formations.
Covington & Burling LLP continued to serve as outside counsel to the Consumer Healthcare Products Association (CHPA), advising on legislation, policy and regulatory strategy and comments related to OTC drugs and devices.
Provided by Chambers
Covington has an excellent, deep bench of seasoned life science transaction lawyers who can lead deals.
Covington is very solid and thorough, bringing a ton of firepower to deals.
Covington has an excellent, deep bench of seasoned life science transaction lawyers who can lead deals.
Covington is very solid and thorough, bringing a ton of firepower to deals.
Provided by Chambers
John is one of the smartest licensing lawyers I have worked with.
Michael Labson is managing partner of the Boston office and cochairs the global life sciences practice. He counsels biotech and pharmaceutical clients on their compliance and relationships with the regulatory agencies.
Denise Esposito is cochair of global life sciences practice. She draws on substantial government and in-house experience to advise life sciences businesses on matters of strategy, policy and regulatory compliance.
Emily Leonard is managing partner of Covington’s Palo Alto office. She advises clients on matters including licensing and technology transfers, joint ventures and strategic partnerships, as well as research and operations-related commercial agreements.
Krista Hessler Carver cochairs global food, drug, and device practice group and the life sciences pharmaceutical and biotechnology industry group. She counsels pharmaceutical and biotechnology businesses on legislative and regulatory developments and procedure, including Hatch-Waxman compliance, life cycle management, digital health and orphan drugs.